Diffusion of isepamicin into cancellous and cortical bone tissue

Journal of Chemotherapy

Volumn 14, Issue 4, 2002, Pages 361-365

  Boselli, Emmanuel ^a   Breilh, D ^a   Bel, J C ^a   Debon, R ^a   Saux, M C ^a   Chassard, D ^a   Allaouchiche, B ^a  

^a HÔTEL DIEU   (France)

Author keywords

Antibiotics; Bone; Diffusion; Isepamicin

Indexed keywords

ANTIBIOTIC AGENT; ISEPAMICIN;

ADULT; AGED; ARTICLE; BONE INFECTION; BONE LEVEL; CANCELLOUS BONE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL BONE; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG EFFICACY; DRUG PENETRATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION;

EID: 0036693978     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2002.14.4.361     Document Type: Article

References (12)

1. Diffusion osseuse des antibiotiques
2. Clinical pharmacokinetics and pharmacodynamics of isepamicin
3. Pharmacokinetics of isepamicin
4. Pharmacokinetics of intravenous administed isepamicin in men
5. Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections
6. Evaluation of fluorescence polarization immunoassay procedure for quantification of isepamicin, a new aminoglycoside antibiotic
7. The inhibitory quotient - A method for interpreting minimum inhibitory concentration data
8. Pénétration tissulaire des antibiotiques
9. Micro-organisms responsible for osteoarticular infections
10. Isepamicin (SCH 21420, 1-N-HAPA Gentamicin B): Microbiological characteristics including antimicrobial potency and spectrum of activity
11. Overview of the efficacy of isepamicin in the adult core clinical trial programme
12. Pharmacokinetics of isepamicin during continuous venovenous hemodiafiltration